- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01413698
Cough Count Validation
People with respiratory infection, asthmatic patients and cystic fibrosis (CF) patients suffer from a multitude of pathologies of airways and are often inflicted with chronic cough.
Treatment of cough in these patients consists of many types of expectorants, cough suppressors, secretion modifiers, inhaled bronchodilators etc. In addition, chest physical therapy (PT) is often prescribed as part of the treatment regime.
The assessment of coughing is currently subjective and based on the symptoms qualitative description as expressed by the patient or parent. Quantitative and objective methods for cough assessment are not available beyond the investigative laboratory and are unique to the specific investigator.
Study Overview
Status
Conditions
Detailed Description
Cough is part of the defense mechanism to protect the lung from foreign particles and remove secretions from the airways . While the cough reflex is essential in protecting the lung from foreign materials and infection, its excessive or chronic presence is both bothersome and might interfere with the quality of life, sleep pattern and exercise tolerance of the patient. Such a symptom may potentially be indicative of an on-going pathological process , .
People with respiratory infection, asthmatic patients and CF patients suffer from a multitude of pathologies of airways and are often inflicted with chronic cough.
Treatment of cough in these patients consists of many types of expectorants, cough suppressors, secretion modifiers, inhaled bronchodilators etc. In addition, chest physical therapy (PT) is often prescribed as part of the treatment regime.
The assessment of coughing is currently subjective and based on the symptoms qualitative description as expressed by the patient or parent. Quantitative and objective methods for cough assessment are not available beyond the investigative laboratory and are unique to the specific investigator.
The primary objective of the study is to evaluate the efficacy and validity of novel cough counting device based on the WIM Technology.
The PulmoTrack™ technology includes the PulmoTrack™ 3010/5050 devices that are intended for the analysis, interpretation and recording of lung sounds, and the Automatic Cough Counting Application.
The recording of the lung sounds will be performed by a PulmoTrack™ 3010/5050 device. The lung sounds can subsequently be analyzed for the presence of wheezes and for the presence of cough by the Automatic Cough Counting Application (ACCA).
The technology enables accurate cough count and timing as well as wheeze detection over time.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Jerusalem, Israel, 91120
- Hadassah Medical Organization
-
Principal Investigator:
- Eitan Kerem, MD
-
Contact:
- Ezekiel balouka, BSc
- Phone Number: 0523121098
- Email: ezekiel@karmelsonix.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 2-80 years.
- Patients with significant chronic cough.
- Patients in hemodynamic stability. Patient is not in respiratory distress.
- Subject or subject's parents/guardians is able to comprehend and give informed consent for participation in the study.
Exclusion Criteria:
- Contraindication to the use of the PulmoTrack™ or performing ARM (Acoustic Respiratory Monitoring).
- Hemodynamic instability and/or SOB.
- Concurrent additional major illness.
- Concurrent participation in any other study.
- Physician objection
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patient with chronic cough
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cough count
Time Frame: recording lasting up to 24 hours
|
recording lasting up to 24 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
WheezeRate (the proportion of wheezing in the respiratory cycle) , respiratory rate, Inspiratory/Expiratory ratio, SPO2, symptom score (according to a questioner)
Time Frame: recording lasting up to 24 hours
|
recording lasting up to 24 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KSI-IL-HHZ-CCF-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Cough
-
Trevi TherapeuticsRecruitingRefractory Chronic CoughCanada, United Kingdom
-
Mayo ClinicRecruitingRefractory Chronic CoughUnited States
-
Stuart MazzoneMelbourne Health; Merck Sharp & Dohme LLC; Monash UniversityNot yet recruitingChronic CoughAustralia
-
ShionogiCompletedChronic CoughUnited States, United Kingdom, Japan, Ukraine, Poland, Czechia
-
Respivant Sciences GmbHRespivant Sciences Inc.TerminatedChronic Cough | IPF | Persistent Cough in IPFUnited States, United Kingdom, Netherlands, Australia, Belgium, New Zealand, Turkey, Italy, Germany, Czechia, Canada
-
Genentech, Inc.RecruitingChronic Refractory Cough (CRC) With Non-atopic Asthma | CRC With Atopic Asthma | Unexplained Chronic Cough | CRC With Chronic Obstructive Pulmonary Disease | CRC With Chronic Obstructive Pulmonary Disease With Chronic BronchitisUnited States, Australia, United Kingdom, Canada
-
Imperial College LondonMerck Sharp & Dohme LLCRecruitingChronic CoughUnited Kingdom
-
Axalbion SARecruiting
-
Ospedale Policlinico San MartinoCompleted
-
Merck Sharp & Dohme LLCCompletedChronic CoughColombia, Guatemala, Korea, Republic of, Peru, Ukraine, United Kingdom, United States, Canada, Germany, Poland, Russian Federation, Spain